Saturday, October 4, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Analyst Downgrade Sends Shockwaves Through Apple’s Investor Base

Robert Sasse by Robert Sasse
October 4, 2025
in Analysis, Nasdaq, Tech & Software
0
Apple Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

A surprising analyst move has placed Apple under significant scrutiny, though the pressure stems from an unexpected source. Rather than reacting to disappointing earnings or sluggish sales figures, the market is digesting a severe rating cut from financial firm Jefferies. The institution has downgraded Apple’s stock to “Underperform,” setting a price target of $205. This projection implies a potential 20% decline from current levels.

The Foldable iPhone Debate Intensifies

The core of Jefferies’ pessimistic assessment revolves around the highly anticipated foldable iPhone. According to the firm’s analysis, Wall Street’s enthusiasm for this upcoming device is misplaced. Analyst Edison Lee issued a stark warning, suggesting that expectations for the so-called iPhone 18 Fold are dramatically overinflated. While market participants are betting on a revolutionary clamshell device, Jefferies estimates annual sales potential at a modest 3 million units.

Several key concerns underpin this cautious outlook:
* Excessively optimistic market forecasts for the iPhone 18 Fold
* Inherently limited market potential for foldable devices as a category
* Unsustainability of price-driven upgrade cycles
* Mounting pressure on profit margins in the absence of genuine innovation

Should investors sell immediately? Or is it worth buying Apple?

A particularly contentious point raised is that the market success of the iPhone 17 has artificially inflated expectations for the foldable model to unrealistic heights. Jefferies highlights the significant risk that Apple may fail to meet these elevated hopes.

A Contrarian Stance in a Divided Market

The stance taken by Jefferies places it firmly against the prevailing market sentiment. Current data shows that among 51 covering analysts, 33 maintain a “Buy” recommendation on Apple shares, while only two, including Jefferies, advocate selling. Despite being in the minority, this critical perspective has the potential to sow doubt among investors, especially with the company’s crucial quarterly results scheduled for release on October 30.

The upcoming Q4 earnings report is poised to serve as a critical test. It will offer clues as to whether the excitement surrounding Apple’s foldable ambitions is justified or if the company is once again overpromising. The investment community is eagerly awaiting any commentary from management regarding AI integration and, more importantly, concrete details about the foldable iPhone’s development. The nature of this guidance is likely to have a decisive impact on the stock’s future trajectory.

Ad

Apple Stock: Buy or Sell?! New Apple Analysis from October 4 delivers the answer:

The latest Apple figures speak for themselves: Urgent action needed for Apple investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 4.

Apple: Buy or sell? Read more here...

Tags: Apple
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Ocugen Stock
Analysis

Ocugen Shares Face Critical Test During Busy Conference Schedule

October 4, 2025
Hims & Hers Health Registered (A) Stock
Healthcare

Leadership Shakeup at Hims & Hers Sends Shares Tumbling

October 4, 2025
Alibaba Stock
AI & Quantum Computing

Alibaba Shares Surge as AI and Cloud Business Fuel Analyst Optimism

October 4, 2025
Next Post
Unitedhealth Stock

Governance Crisis and Strategic Retreat Plague UnitedHealth

Lockheed Martin Stock

Lockheed Martin Stock Soars on Wave of Major Defense Contracts

Wolfspeed Stock

Wolfspeed Shares Stabilize Following Bankruptcy Exit Rally

Recommended

Compass Stock

Compass Stock: Record Growth Defies Shrinking Market

2 months ago
Applovin Stock

Applovin’s S&P 500 Inclusion Fuels Record-Breaking Rally

2 weeks ago
Carvana Stock

Carvana Leadership’s Stock Sales Raise Questions Amid Strong Performance

1 month ago
Hims & Hers Stock

Regulatory Scrutiny Intensifies for Hims & Hers Following Super Bowl Ad

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Insider Sales at Alphabet Amid Stock’s Ascent to New Highs

Rocket Lab Shares Soar Following Major Contract and NASA Partnership

Assembly Biosciences Stock Surges on Critical Technical Breakthrough

Regulatory Breakthrough Clears Path for MicroStrategy’s Bitcoin Strategy

Intel’s Resurgence Fueled by Government Backing and Strategic Partnerships

Defense Giant Lockheed Martin Secures Major Naval Contract

Trending

Ocugen Stock
Analysis

Ocugen Shares Face Critical Test During Busy Conference Schedule

by Dieter Jaworski
October 4, 2025
0

The biotechnology firm Ocugen has captured market attention with a remarkable performance surge, gaining more than 26%...

Hims & Hers Health Registered (A) Stock

Leadership Shakeup at Hims & Hers Sends Shares Tumbling

October 4, 2025
Alibaba Stock

Alibaba Shares Surge as AI and Cloud Business Fuel Analyst Optimism

October 4, 2025
Alphabet Stock

Insider Sales at Alphabet Amid Stock’s Ascent to New Highs

October 4, 2025
Rocket Lab USA Stock

Rocket Lab Shares Soar Following Major Contract and NASA Partnership

October 4, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocugen Shares Face Critical Test During Busy Conference Schedule
  • Leadership Shakeup at Hims & Hers Sends Shares Tumbling
  • Alibaba Shares Surge as AI and Cloud Business Fuel Analyst Optimism

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com